Document is current

Article History

Received: 8 January 2026

Accepted: 11 January 2026

First Online: 17 March 2026

Declarations

:

: Virginia Arrazubi reports Advisory Board, and Speaker from BMS and MSD and Speaker from Beigene, Lilly, Astellas and Organon. Marc Oliva reports Advisory Board, and Speaker from Merck; Other from Transgene and Guardant Health; personal fees from Obatica; Grant from Roche and Speaker from BMS. Pedro Pérez reports Speaker, and personal fees, non-financial support from MSD and Merck, and Speaker, Grant, personal fees, non-financial support from BMS. Jordi Rubió-Casadevall reports Advisory Board from Novartis, Sanofi, Merck and Lilly, and Speaker from IPSEN. Gemma Bruixola reports Speaker from Merck, BMS and MSD. Beatriz Cirauqui reports Advisory Board, Speaker, Grant from Merck, BMS and MSD, and Speaker from Pfizer. Antonio Rueda Domínguez reports Advisory Board, and Speaker from Roche, Takeda, Gilead and Merck; Speaker from MSD and BMS. Lara Iglesias, Alberto Carral and Beatriz Castelo have nothing to disclose.

: Not applicable.

: The manuscript does not contain clinical studies or patient data.